Top news of the week: 19.09.2022.
Report
Amyotrophic lateral sclerosis
Complement system
Investment banking
Investment
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report.
Co. Advancing Drug Class With Broad Potential: https://t.co/Dxv5tH39iV
$ANNX #biopharma #stocks @annexonbio
OpenCo. Advancing Drug Class With Broad Potential Research Report
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report.